Skip to content
StockMarketAgent
Healthcare / Medical - Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

AIM/GDR stock hub

AIM/GDR has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

AIM/GDRis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
16.9M
London Stock Exchange AIM
Market data

Live price

Current market quote for this ticker.

Current price
AIM/GDR
In the news

Latest news · AIM/GDR

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.9P50 16.9P75 23.5
Trailing P/En/a
P25 15.9P50 22.9P75 35.8
ROE-402.5
P25 -54.2P50 2.1P75 13.7
ROIC-215.1
P25 -38.1P50 3.3P75 11.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All AIM/GDR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
175
Groups with data
11
Currency
GBP
Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
United Kingdom
Country code
UK
Employees
43
Employees Change
3%
Employees Change Percent
7.5
Enterprise value
GBX 17M
Exchange
London Stock Exchange AIM
Financial currency
GBP
First seen
2026-05-10
Industry
Medical - Diagnostics & Research
Isin
GB00B1VKB244
Last refreshed
2026-05-10
Market cap
GBX 16.9M
Price
GBX 1.08
Price currency
GBX
Rev Per Employee
27,302.33x
Sector
Healthcare
Sic
2836
Symbol
aim/GDR
Website
https://www.genedriveplc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-31.69%
EV Earnings
-3.18x
EV/FCF
-4.35x
EV/Sales
14.46x
FCF yield
-23.15%
P/B ratio
-40.62x
P/S ratio
14.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

12
MetricValue
Gross margin
-283.99%
Gross Profit
GBX -3.3M
Net Income
GBX -5.3M
Net Income Growth Years
1%
Pretax Margin
-469.59%
Profit Per Employee
GBX -124,256
ROA
-117.8
Roa5y
-58.62
ROCE
-6,387.1
ROE
-402.5
Roe5y
-226.8
ROIC
-215.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

13
MetricValue
Cagr10y
-34.18%
Cagr15y
-31.07%
Cagr1y
-26.71%
Cagr3y
-59.67%
Cagr5y
-55.36%
EPS Growth Quarters
3
EPS Growth Years
3
Revenue Growth
91.52x
Revenue Growth Q
62.86x
Revenue Growth Quarters
5x
Revenue Growth Years
3x
Revenue Growth3 Y
32.82x
Revenue Growth5 Y
84.44x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

16
MetricValue
Asset Turnover
GBX 0.41
Assets
GBX 1.8M
Cash
GBX 387,000
Current Assets
GBX 1.6M
Current Liabilities
GBX 1.7M
Debt
GBX 500,000
Debt FCF
GBX -0.13
Equity
GBX -415,000
Liabilities
GBX 2.2M
Long Term Assets
GBX 109,000
Long Term Liabilities
GBX 500,000
Net Cash
GBX -113,000
Net Cash By Market Cap
GBX -0.67
Tangible Book Value
GBX -415,000
Tangible Book Value Per Share
GBX -0
WACC
9.05

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.99
Inventory Turnover
12.75
Net Working Capital
GBX -411,000
Quick ratio
0.78
Working Capital
GBX -24,000
Working Capital Turnover
GBX 0.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-91.19%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-98.47%
1Y total return
-26.69%
200-day SMA
0.86
3Y total return
-93.44%
50-day SMA
0.99
50-day SMA vs 200-day SMA
50over200
5Y total return
-98.23%
All Time High
585
All Time High Change
-99.82%
All Time High Date
2013-07-30
All Time Low
0.19
All Time Low Change
466.32%
All Time Low Date
2025-09-24
ATR
0.11
Beta
0.92
Beta1y
-1.37
Beta2y
-0.46
Ch YTD
22.97
High
1.25
High52
1.88
High52 Date
2025-06-02
High52ch
-42.61%
Low
0.92
Low52
0.19
Low52 Date
2025-09-24
Low52ch
466.32%
Ma50ch
8.82%
Price vs 200-day SMA
24.51%
RSI
64.35
RSI Monthly
39.46
RSI Weekly
52.99
Sharpe ratio
0.45x
Sortino ratio
0.8
Total Return
-91.19%
Tr YTD
24.41
Tr15y
-99.62%
Tr1m
13.26%
Tr1w
13.26%
Tr3m
-5.34%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
GBX -5.4M
Operating margin
-462.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
885,055,506%
Net Borrowing
500,000
Shares Insiders
35.58%
Shares Institutions
42.96%
Shares Out
1,605,568,256
Shares Qo Q
43.56%
Shares Yo Y
91.19%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

52
MetricValue
Adjusted FCF
GBX -4M
Average Volume
7,568,482.8x
Bv Per Share
-0
CAPEX
GBX -10,000
Ch10y
-98.8
Ch15y
-99.71
Ch1m
13.26
Ch1w
13.26
Ch1y
-27.54
Ch3m
-6.43
Ch3y
-94.81
Ch5y
-98.61
Ch6m
23.68
Change
13.26%
Change From Open
10.99
Close
0.95
Days Gap
2.05
Depreciation Amortization
46,000
Dollar Volume
51,031,518.7
Earnings Date
2026-04-02
EBIT
GBX -5.4M
EBITDA
GBX -5.4M
EPS
GBX -0.01
F Score
3
FCF
GBX -3.9M
FCF EV Yield
-23x
FCF Per Share
GBX -0
Financing CF
2,187,000
Fiscal Year End
June
Founded
2,000
Income Tax
GBX -170,000
Investing CF
-5,000
Is Primary Listing
1
Last Earnings Date
2025-12-31
Last Report Date
2025-12-31
Ma150
0.91
Ma150ch
18.48%
Ma20
0.95
Ma20ch
13.24%
Net CF
-1,711,000
Open
0.97
Position In Range
46.85
Ppne
109,000
Price Date
2026-05-08
Relative Volume
6.44x
Revenue
1,174,000x
SBC By Revenue
6.98x
Share Based Comp
82,000
Tax By Revenue
-14.48x
Tr6m
25.12%
Volume
47,427,062
Z Score
-59.2
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does AIM/GDR pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/GDR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-26.7%
S&P 500 1Y: n/a
3Y total return
-93.4%
S&P 500 3Y: n/a
5Y total return
-98.2%
S&P 500 5Y: n/a
10Y total return
-98.5%
S&P 500 10Y: n/a
Ownership

Who owns AIM/GDR?

Insider, institutional, and short-interest positioning.

Institutional ownership
+43.0%
Share of float held by funds and institutions
Insider ownership
+35.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+91.2%
Negative means the company is buying back shares.
Technical

AIM/GDR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
64.3
Neutral momentum band
Price vs 200-day MA
+24.5%
50/200-day relationship not available
Beta (5Y)
0.92
Moves roughly with the market
Sharpe ratio
0.45
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About AIM/GDR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/GDR stock rating?

aim/GDR is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/GDR analysis?

The full report lives at /stocks/aim/GDR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/GDR?

The latest report frames aim/GDR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/GDR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

aim/GDR stock profile: metrics, valuation and analysis | StockMarketAgent.AI